
Dyne Therapeutics Grants Equity Awards to 17 New Employees
Dyne Therapeutics, Inc. has granted inducement equity awards to 17 newly hired employees. These awards, consisting of stock options and restricted stock units, were made in accordance with Nasdaq Listing Rule 5635(c)(4) to incentivize new hires. The stock options allow the purchase of up to 213,000 shares at the closing price on November 17, 2026, with vesting over four years. Restricted stock units cover 67,200 shares and also vest over four years. These grants are governed by the company's 2024 Inducement Stock Incentive Plan.
Key Highlights
- Dyne Therapeutics granted inducement equity awards to 17 new employees.
- Awards include stock options for up to 213,000 shares.
- Awards include restricted stock units for 67,200 shares.
- Stock options have a 10-year term and vest over four years.
- Restricted stock units vest over four years in equal annual installments.
- Awards are made under Dyne's 2024 Inducement Stock Incentive Plan.
Price Impact
More from DYN
Dyne Therapeutics Q3 Net Loss Widens to $193.6M; FDA Review Ongoing
Dyne Therapeutics Q2 Net Loss $178.6M; FDA Accepts DMD BLA with Priority Review
Dyne Therapeutics BLA for z-rostudirsen in DMD Accepted by FDA with Priority Review